Nutex Health Inc.
NUTX
$187.60
$1.760.95%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.88% | 40.95% | 82.36% | 236.03% | 187.10% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.88% | 40.95% | 82.36% | 236.03% | 187.10% |
| Cost of Revenue | 7.24% | 47.73% | 55.90% | 101.77% | 75.40% |
| Gross Profit | 6.59% | 34.91% | 113.42% | 556.44% | 508.61% |
| SG&A Expenses | -123.45% | -66.74% | -9.24% | 362.92% | 378.80% |
| Depreciation & Amortization | 1.97% | 5.29% | 8.21% | 12.25% | 13.48% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -33.97% | 19.50% | 41.05% | 135.32% | 113.53% |
| Operating Income | 101.62% | 81.22% | 184.96% | 1,201.39% | 1,327.75% |
| Income Before Tax | 70.86% | 38.04% | 122.88% | 1,208.89% | 731.67% |
| Income Tax Expenses | 70.10% | 64.98% | 328.89% | 2,139.76% | 2,129.02% |
| Earnings from Continuing Operations | 71.06% | 31.58% | 90.24% | 912.30% | 635.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 10.08% | -32.37% | -156.55% | -1,535.25% | -1,167.61% |
| Net Income | 219.31% | 30.81% | 35.88% | 393.11% | 248.72% |
| EBIT | 101.62% | 81.22% | 184.96% | 1,201.39% | 1,327.75% |
| EBITDA | 93.70% | 74.85% | 163.57% | 725.98% | 643.68% |
| EPS Basic | 140.97% | -0.52% | 7.99% | 322.79% | 222.31% |
| Normalized Basic EPS | 506.73% | 121.53% | 187.71% | 1,261.02% | 473.61% |
| EPS Diluted | 153.29% | 0.43% | 2.88% | 307.23% | 211.78% |
| Normalized Diluted EPS | 593.08% | 134.33% | 193.46% | 1,149.02% | 419.96% |
| Average Basic Shares Outstanding | 25.73% | 27.71% | 26.32% | 23.22% | 19.00% |
| Average Diluted Shares Outstanding | 23.19% | 24.26% | 30.43% | 31.55% | 25.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |